Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
This study has been completed.
Study NCT00025779 Information provided by National Institute of Mental Health (NIMH)
First Received: October 23, 2001 Last Updated: July 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autistic Disorder
Pervasive Development Disorders
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
Child Development Disorders, Pervasive
Developmental Disabilities
Disease
Hyperkinesis
More general conditions related to this trial
Attention Deficit and Disruptive Behavior Disorders
Dyskinesias
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurologic Manifestations
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
methylphenidate
guanfacine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content
